Company: PSTV
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047698
Chunk: 122

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 5
Chunk 122
---
Market Prices 

Market Information

The Company’s common stock is listed on the Nasdaq Capital Market under the symbol “PSTV.”

As of March 21, 2025, the Company had approximately seventeen record holders of common stock. Because many of the Company’s outstanding shares are held by brokers and other institutions on behalf of stockholders, the Company is unable to estimate the total number of individual stockholders represented by these record holders.

The Company has never paid cash dividends to its stockholders. The Company intends to retain future earnings for use in its business and does not anticipate paying cash dividends on its common stock in the foreseeable future. Any future dividend policy will be determined by the Board and will be based upon various factors, including the Company’s results of operations, financial condition, current and anticipated cash needs, future prospects, contractual restrictions and other factors as the Board may deem relevant.

Equity Compensation Plan Information 

The following table gives information as of December 31, 2024 about shares of our common stock that may be issued upon the exercise of outstanding options, and shares remaining available for issuance under all of our equity compensation plans:

    Plan Category
     
    Number of securities to be issued upon exercise of outstanding options, warrants and rights
     
    Weighted-average exercise price of outstanding options, warrants and rights
     
    Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

    (a)
     
    (b)
     
    (c)

    Equity compensation plans approved by security holders (1)
     
    23,897
     
    $43.42
     
    62,908

    Equity compensation plans not approved by security holders (2) 
     
    574,643
     
    $5.57
     
    692,596

    Total
     
    598,540
     
    $7.08
     
    755,504

1.Represents (i) options outstanding that were issued under the 2004 Stock Option and Stock Purchase Plan which expired in August 2004 and (ii) the 2015 New Employee Incentive Plan.

2.See Notes to the Financial Statements included elsewhere herein for a description of our 2020 Stock Incentive Plan.